235 related articles for article (PubMed ID: 10419192)
1. Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments.
Di Marzo V; De Petrocellis L; Bisogno T; Melck D
Lipids; 1999; 34 Suppl():S319-25. PubMed ID: 10419192
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
Sugiura T; Kobayashi Y; Oka S; Waku K
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
[TBL] [Abstract][Full Text] [Related]
3. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators.
Di Marzo V
Life Sci; 1999; 65(6-7):645-55. PubMed ID: 10462065
[TBL] [Abstract][Full Text] [Related]
4. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
Reggio PH; Traore H
Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
[TBL] [Abstract][Full Text] [Related]
5. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.
Di Marzo V; Bisogno T; De Petrocellis L; Melck D; Martin BR
Curr Med Chem; 1999 Aug; 6(8):721-44. PubMed ID: 10469888
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptors and their endogenous ligands.
Sugiura T; Waku K
J Biochem; 2002 Jul; 132(1):7-12. PubMed ID: 12097154
[TBL] [Abstract][Full Text] [Related]
7. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
8. Presence and regulation of the endocannabinoid system in human dendritic cells.
Matias I; Pochard P; Orlando P; Salzet M; Pestel J; Di Marzo V
Eur J Biochem; 2002 Aug; 269(15):3771-8. PubMed ID: 12153574
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid.
Fowler CJ; Jonsson KO; Andersson A; Juntunen J; Järvinen T; Vandevoorde S; Lambert DM; Jerman JC; Smart D
Biochem Pharmacol; 2003 Sep; 66(5):757-67. PubMed ID: 12948856
[TBL] [Abstract][Full Text] [Related]
10. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration.
Hansen HH; Schmid PC; Bittigau P; Lastres-Becker I; Berrendero F; Manzanares J; Ikonomidou C; Schmid HH; Fernández-Ruiz JJ; Hansen HS
J Neurochem; 2001 Sep; 78(6):1415-27. PubMed ID: 11579150
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid metabolic pathways and enzymes.
Ligresti A; Cascio MG; Di Marzo V
Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679
[TBL] [Abstract][Full Text] [Related]
12. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand.
Goparaju SK; Ueda N; Yamaguchi H; Yamamoto S
FEBS Lett; 1998 Jan; 422(1):69-73. PubMed ID: 9475172
[TBL] [Abstract][Full Text] [Related]
13. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges.
Schmid HH; Schmid PC; Berdyshev EV
Chem Phys Lipids; 2002 Dec; 121(1-2):111-34. PubMed ID: 12505695
[TBL] [Abstract][Full Text] [Related]
14. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?
Fowler CJ; Jacobsson SO
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):193-200. PubMed ID: 12052035
[TBL] [Abstract][Full Text] [Related]
15. FAAH and anandamide: is 2-AG really the odd one out?
Di Marzo V; Maccarrone M
Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study.
Romero J; Hillard CJ; Calero M; Rábano A
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):85-93. PubMed ID: 12008024
[TBL] [Abstract][Full Text] [Related]
17. N-arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues.
Sugiura T; Kondo S; Sukagawa A; Tonegawa T; Nakane S; Yamashita A; Waku K
J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):51-6. PubMed ID: 8906545
[TBL] [Abstract][Full Text] [Related]
18. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
19. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response.
De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V
Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]